Chk1 targeting reactivates PP2A tumor suppressor activity in cancer cells

Checkpoint kinase Chk1 is constitutively active in many cancer cell types and new generation Chk1 inhibitors show marked antitumor activity as single agents. Here we present a hitherto unrecognized mechanism that contributes to the response of cancer cells to Chk1 targeted therapy. Inhibiting chroni...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Khanna, Anchit, Kauko, Otto, Böckelman, Camilla, Laine, Anni, Schreck, Ilona, Partanen, Johanna I., Szwajda, Agnieszka, Bormann, Stefanie, Bilgen, Turker, Helenius, Merja, Pokharel, Yuba R., Pimanda, John, Russel, Mike R., Haglund, Caj, Cole, Kristina A., Klefström, Juha, Aittokallio, Tero, Weiss, Carsten, Ristimäki, Ari, Visakorpi, Tapio, Westermarck, Jukka
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2013
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC3870284/
https://ncbi.nlm.nih.gov/pubmed/24072747
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-13-1002
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg